| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000257776.05673.FF |
| P8608 | Fatcat ID | release_kcvceohi6jewxb2yt272toj5wm |
| P698 | PubMed publication ID | 17218605 |
| P50 | author | Shulamit Levenberg | Q6983543 |
| P2093 | author name string | Gil Arbel | |
| Lior Gepstein | |||
| Oren Caspi | |||
| Ayelet Lesman | |||
| Amira Gepstein | |||
| Yaara Basevitch | |||
| Irit Huber Manhal Habib | |||
| P433 | issue | 2 | |
| P921 | main subject | human embryonic stem cell | Q59626782 |
| tissue engineering | Q1540285 | ||
| P304 | page(s) | 263-272 | |
| P577 | publication date | 2007-01-11 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Tissue engineering of vascularized cardiac muscle from human embryonic stem cells | |
| P478 | volume | 100 |
| Q30537357 | 2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture |
| Q37715555 | 3-dimensional structures to enhance cell therapy and engineer contractile tissue. |
| Q54975606 | 3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects. |
| Q89216645 | 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling |
| Q64227923 | 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration |
| Q57170716 | A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation |
| Q38006734 | A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration. |
| Q36947690 | A mathematical model for analyzing the elasticity, viscosity, and failure of soft tissue: comparison of native and decellularized porcine cardiac extracellular matrix for tissue engineering |
| Q33701439 | A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds. |
| Q46292510 | A novel mixed-type stem cell pellet for cementum/periodontal ligament-like complex |
| Q46232337 | A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells |
| Q38101863 | A plethora of human pluripotent stem cells |
| Q34477403 | Adhesion proteins, stem cells, and arrhythmogenesis |
| Q48334029 | Adipose-derived perivascular mesenchymal stromal/stem cells promote functional vascular tissue engineering for cardiac regenerative purposes. |
| Q37815089 | Adult stem cells: from new cell sources to changes in methodology |
| Q38184951 | Advances in tissue engineering through stem cell-based co-culture |
| Q30566351 | Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. |
| Q30428010 | An engineered muscle flap for reconstruction of large soft tissue defects |
| Q36800040 | Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis |
| Q26801226 | Applications of regenerative medicine in organ transplantation |
| Q37886790 | Basement membrane matrix (BME) has multiple uses with stem cells. |
| Q39653342 | Bioactive scaffolds for engineering vascularized cardiac tissues |
| Q47270959 | Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application |
| Q91740487 | Bioengineering an Artificial Human Blood⁻Brain Barrier in Rodents |
| Q49833396 | Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. |
| Q36117532 | Bioengineering heart muscle: a paradigm for regenerative medicine |
| Q38128026 | Bioengineering heart tissue for in vitro testing |
| Q57470597 | Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources |
| Q38543476 | Bioengineering methods for myocardial regeneration |
| Q35787037 | Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering |
| Q55066749 | Biomaterial property-controlled stem cell fates for cardiac regeneration. |
| Q35571962 | Biomaterial strategies for alleviation of myocardial infarction |
| Q26852224 | Biomaterials to enhance stem cell function in the heart |
| Q36737037 | Biomimetic approach to cardiac tissue engineering |
| Q34148059 | Biomimetic poly(ethylene glycol)-based hydrogels as scaffolds for inducing endothelial adhesion and capillary-like network formation |
| Q30833397 | Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip |
| Q33939491 | Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. |
| Q41192534 | Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes |
| Q89433765 | Can We Engineer a Human Cardiac Patch for Therapy? |
| Q39812568 | Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues |
| Q38206983 | Cardiac Tissue Vascularization: From Angiogenesis to Microfluidic Blood Vessels |
| Q24615347 | Cardiac applications for human pluripotent stem cells |
| Q38079141 | Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research |
| Q38041270 | Cardiac repair and restoration using human embryonic stem cells |
| Q38647934 | Cardiac spheroids as promising in vitro models to study the human heart microenvironment. |
| Q37766145 | Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis |
| Q34377754 | Cardiac tissue development for delivery of embryonic stem cell-derived endothelial and cardiac cells in natural matrices |
| Q37261443 | Cardiac tissue engineering using stem cells |
| Q37869908 | Cardiac tissue engineering: a clinical perspective |
| Q37423133 | Cardiac tissue engineering: implications for pediatric heart surgery |
| Q38172390 | Cardiac tissue engineering: renewing the arsenal for the battle against heart disease |
| Q92860231 | Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling |
| Q47160787 | Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. |
| Q37512327 | Cell and gene therapy approaches for cardiac vascularization |
| Q37444377 | Cell therapies for therapeutic angiogenesis: back to the bench |
| Q37583950 | Challenges in cardiac tissue engineering |
| Q38970615 | Classic Studies on the Potential of Stem Cell Neuroregeneration |
| Q50087955 | Co-Differentiation of Human Pluripotent Stem Cells-Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three-Dimensional Model of Cardiac Microtissue |
| Q36007683 | Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK/JNK signaling |
| Q33690013 | Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. |
| Q92712250 | Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation |
| Q37415012 | Composite cell sheet for periodontal regeneration: crosstalk between different types of MSCs in cell sheet facilitates complex periodontal-like tissue regeneration |
| Q57292609 | Concise Review: The Current State of Human in vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering |
| Q38120722 | Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology |
| Q38063849 | Concise review: cell therapy and tissue engineering for cardiovascular disease |
| Q38050451 | Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine |
| Q26863381 | Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering |
| Q37114446 | Degradable poly(2-hydroxyethyl methacrylate)-co-polycaprolactone hydrogels for tissue engineering scaffolds |
| Q34811805 | Developing vasculature and stroma in engineered human myocardium |
| Q33699342 | Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells. |
| Q34047971 | Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture |
| Q92184932 | Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics |
| Q36926060 | Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes |
| Q37542604 | Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells |
| Q37805824 | Embryonic and embryonic-like stem cells in heart muscle engineering |
| Q36862067 | Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats |
| Q38027106 | Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair |
| Q38046445 | Endothelialization approaches for viable engineered tissues |
| Q40828631 | Engineered Vascularized Muscle Flap |
| Q37870320 | Engineered cardiac tissues |
| Q57178584 | Engineered circulatory scaffolds for building cardiac tissue |
| Q37294318 | Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart |
| Q36822815 | Engineered human cardiac tissue |
| Q49455393 | Engineered human pluripotent stem cell-derived cardiac cells and tissues for electrophysiological studies |
| Q37947517 | Engineered tissue grafts: opportunities and challenges in regenerative medicine. |
| Q34342360 | Engineered vascular beds provide key signals to pancreatic hormone-producing cells |
| Q55287570 | Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair. |
| Q37799363 | Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders |
| Q37872006 | Engineering cell platforms for myocardial regeneration. |
| Q24657199 | Engineering tissue from human embryonic stem cells |
| Q42405847 | Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells |
| Q36938375 | From scrawny to brawny: the quest for neomusculogenesis; smart surfaces and scaffolds for muscle tissue engineering |
| Q36212655 | Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model |
| Q49423373 | Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro |
| Q27024431 | Functional cardiac tissue engineering |
| Q37344593 | Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes |
| Q91012494 | Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells |
| Q24630666 | Growth of engineered human myocardium with mechanical loading and vascular coculture |
| Q34341522 | Harnessing developmental processes for vascular engineering and regeneration |
| Q24562846 | Heart regeneration |
| Q38211168 | Heart regeneration with engineered myocardial tissue |
| Q34995661 | Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo |
| Q38842308 | Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model |
| Q37911584 | Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q37262393 | Human embryonic stem cells for cardiomyogenesis |
| Q34750670 | Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. |
| Q45929629 | Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering. |
| Q21134989 | Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology |
| Q39050993 | Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening |
| Q41231682 | Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. |
| Q37372183 | Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives |
| Q47808382 | Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology |
| Q27323532 | Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts |
| Q38088809 | Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes |
| Q50452815 | In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells. |
| Q48049093 | In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish. |
| Q35314819 | In vivo bioluminescence for tracking cell fate and function |
| Q35162679 | In vivo cell tracking with bioluminescence imaging |
| Q38041929 | Induced pluripotent stem cells for cardiac repair |
| Q46985469 | Influence of Electromechanical Activity on Cardiac Differentiation of Mouse Embryonic Stem Cells. |
| Q47819879 | Inspiration from heart development: Biomimetic development of functional human cardiac organoids |
| Q33605870 | Insulin-like growth factor-I and slow, bi-directional perfusion enhance the formation of tissue-engineered cardiac grafts |
| Q37691970 | Integrating in vitro organ-specific function with the microcirculation |
| Q40886587 | Integration and regression of implanted engineered human vascular networks during deep wound healing. |
| Q33586605 | Intramyocardial fibroblast myocyte communication |
| Q58698138 | It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease |
| Q38174018 | Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes. |
| Q37206811 | Materials science and tissue engineering: repairing the heart |
| Q38843274 | Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct. |
| Q28550738 | Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues |
| Q27329454 | Mechanical Stress Promotes Maturation of Human Myocardium From Pluripotent Stem Cell-Derived Progenitors |
| Q39444582 | Meniscus induced self organization of multiple deep concave wells in a microchannel for embryoid bodies generation |
| Q27341916 | Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay |
| Q38851260 | Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities |
| Q38788603 | Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models. |
| Q36272346 | Modular assembly of thick multifunctional cardiac patches |
| Q36742875 | Morphogenesis of 3D vascular networks is regulated by tensile forces |
| Q34978776 | Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes |
| Q47871478 | Myocardial Tissue Engineering for Regenerative Applications |
| Q37176440 | Myocardial repair: from salvage to tissue reconstruction |
| Q38193042 | Myocardial tissue engineering: in vitro models |
| Q37578552 | Myocardial tissue engineering: the quest for the ideal myocardial substitute |
| Q35893322 | Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. |
| Q59016381 | Nanoscaffolds for Guided Cardiac Repair: The New Therapeutic Challenge of Regenerative Medicine |
| Q39673715 | Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells |
| Q38952166 | New semi-biodegradable materials from semi-interpenetrated networks of poly(ϵ-caprolactone) and poly(ethyl acrylate). |
| Q36801608 | Nonsteady state oxygen transport in engineered tissue: implications for design |
| Q54691127 | Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes. |
| Q37290122 | Optical spectroscopy and imaging for the noninvasive evaluation of engineered tissues |
| Q50318682 | Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel. |
| Q35109026 | Optimizing recellularization of whole decellularized heart extracellular matrix |
| Q37997980 | Organ repair and regeneration: an overview. |
| Q84435159 | Panoramic view of the Fifth International Symposium on Stem Cell Therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain) |
| Q46240809 | Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. |
| Q57913855 | Perinatal Tissue-Derived Endothelial Progenitor Cells |
| Q38035789 | Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes |
| Q92994217 | Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function |
| Q24652369 | Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue |
| Q38477532 | Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration |
| Q27340010 | Platform technology for scalable assembly of instantaneously functional mosaic tissues |
| Q33875374 | Pluripotent stem cell derived cardiomyocytes for cardiac repair |
| Q38665521 | Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function |
| Q34520935 | Present state and future perspectives of using pluripotent stem cells in toxicology research |
| Q34802980 | Preservation of Capillary-beds in Rat Lung Tissue Using Optimized Chemical Decellularization |
| Q50581951 | Prevascular structures promote vascularization in engineered human adipose tissue constructs upon implantation. |
| Q37471583 | Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature |
| Q37329635 | Prevascularization of cardiac patch on the omentum improves its therapeutic outcome |
| Q45974966 | Prevascularization of self-organizing engineered heart tissue by human umbilical vein endothelial cells abrogates contractile performance. |
| Q36661266 | Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications |
| Q34245487 | Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming |
| Q35589725 | Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. |
| Q33617317 | Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts |
| Q39176130 | Reprogramming approaches in cardiovascular regeneration |
| Q33649957 | Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering |
| Q37414585 | Scaffold-free human cardiac tissue patch created from embryonic stem cells |
| Q37356210 | Scaffold-free vascular tissue engineering using bioprinting |
| Q43083088 | Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. |
| Q37400353 | Spatiotemporal tracking of cells in tissue-engineered cardiac organoids |
| Q48774892 | State-of-the-Art in Tissue-Engineered Heart Repair |
| Q51067725 | Stem Cell Banking and Its Impact on Cardiac Regenerative Medicine. |
| Q37995019 | Stem cell therapy for cardiac disease |
| Q37900227 | Stem cell-based cardiac tissue engineering |
| Q38050281 | Stem cell-based therapy for ischemic heart disease. |
| Q37164041 | Stem-cell-based therapy and lessons from the heart |
| Q57340497 | Strategies and Challenges for Bio-inspired Cardiovascular Biomaterials |
| Q37912067 | Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction |
| Q30746389 | Stromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue |
| Q33539819 | Surface-patterned electrode bioreactor for electrical stimulation |
| Q38700082 | Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. |
| Q37945458 | The cardiogenic niche as a fundamental building block of engineered myocardium |
| Q36374351 | The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction |
| Q33872259 | The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding |
| Q38274270 | The role of tissue engineering and biomaterials in cardiac regenerative medicine |
| Q36234392 | Therapeutic effect of mesenchymal stem cells on experimentally induced hypertensive cardiomyopathy in adult albino rats |
| Q38077943 | Therapeutic potential of perivascular cells from human pluripotent stem cells |
| Q36294610 | Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration |
| Q41528472 | Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q84859409 | Three-dimensional biomaterials for the study of human pluripotent stem cells |
| Q37711224 | Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells |
| Q40199212 | Tissue engineering approaches for the development of a contractile cardiac patch. |
| Q37784654 | Tissue engineering by self-assembly and bio-printing of living cells |
| Q26799470 | Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening |
| Q24623082 | Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes |
| Q34347650 | Trends in cardiovascular engineering: organizing the human heart |
| Q37683821 | Two dimensional electrophysiological characterization of human pluripotent stem cell-derived cardiomyocyte system. |
| Q51589736 | Ultrasound-guided photoacoustic imaging-directed re-endothelialization of acellular vasculature leads to improved vascular performance. |
| Q38076534 | Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis |
| Q50201254 | Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis. |
| Q57171867 | Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering |
Search more.